Investments
Jan. 28, 2012
Patent reform could keep investors out of small biotech companies
Patent reform has given small biotechnology startups exactly what they don't need right now: a dose of added uncertainty.
Daily Journal Staff Writer
Patent reform has given small biotechnology startups exactly what they don't need right now: a dose of added uncertainty.
The America Invents Act of 2011, with its switch from a first-to-invent to a first-to-file patent system and opportunities for pre-litigation challenges at the patent office, favors big pharmaceutical and medical device companies with millions - or even billions of dollars - ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In